Cargando…
Retraction: NEAT1 Overexpression Indicates a Poor Prognosis and Induces Chemotherapy Resistance via the miR-491-5p/SOX3 Signaling Pathway in Ovarian Cancer
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842386/ https://www.ncbi.nlm.nih.gov/pubmed/35173772 http://dx.doi.org/10.3389/fgene.2022.861109 |
| _version_ | 1784651039413108736 |
|---|---|
| author | Frontiers Editorial Office, |
| author_facet | Frontiers Editorial Office, |
| author_sort | Frontiers Editorial Office, |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8842386 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88423862022-02-15 Retraction: NEAT1 Overexpression Indicates a Poor Prognosis and Induces Chemotherapy Resistance via the miR-491-5p/SOX3 Signaling Pathway in Ovarian Cancer Frontiers Editorial Office, Front Genet Genetics Frontiers Media S.A. 2022-01-31 /pmc/articles/PMC8842386/ /pubmed/35173772 http://dx.doi.org/10.3389/fgene.2022.861109 Text en Copyright © 2022 Frontiers Production Office. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Genetics Frontiers Editorial Office, Retraction: NEAT1 Overexpression Indicates a Poor Prognosis and Induces Chemotherapy Resistance via the miR-491-5p/SOX3 Signaling Pathway in Ovarian Cancer |
| title | Retraction: NEAT1 Overexpression Indicates a Poor Prognosis and Induces Chemotherapy Resistance via the miR-491-5p/SOX3 Signaling Pathway in Ovarian Cancer |
| title_full | Retraction: NEAT1 Overexpression Indicates a Poor Prognosis and Induces Chemotherapy Resistance via the miR-491-5p/SOX3 Signaling Pathway in Ovarian Cancer |
| title_fullStr | Retraction: NEAT1 Overexpression Indicates a Poor Prognosis and Induces Chemotherapy Resistance via the miR-491-5p/SOX3 Signaling Pathway in Ovarian Cancer |
| title_full_unstemmed | Retraction: NEAT1 Overexpression Indicates a Poor Prognosis and Induces Chemotherapy Resistance via the miR-491-5p/SOX3 Signaling Pathway in Ovarian Cancer |
| title_short | Retraction: NEAT1 Overexpression Indicates a Poor Prognosis and Induces Chemotherapy Resistance via the miR-491-5p/SOX3 Signaling Pathway in Ovarian Cancer |
| title_sort | retraction: neat1 overexpression indicates a poor prognosis and induces chemotherapy resistance via the mir-491-5p/sox3 signaling pathway in ovarian cancer |
| topic | Genetics |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842386/ https://www.ncbi.nlm.nih.gov/pubmed/35173772 http://dx.doi.org/10.3389/fgene.2022.861109 |
| work_keys_str_mv | AT frontierseditorialoffice retractionneat1overexpressionindicatesapoorprognosisandinduceschemotherapyresistanceviathemir4915psox3signalingpathwayinovariancancer |